Published in Drug Alcohol Depend on May 18, 2013
HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect (2013) 1.08
HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers. Addiction (2014) 0.87
Internalized HIV and Drug Stigmas: Interacting Forces Threatening Health Status and Health Service Utilization Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS Behav (2016) 0.83
Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals? Ann Epidemiol (2014) 0.82
Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction (2015) 0.79
Two Independent HIV Epidemics in Saint Petersburg, Russia Revealed by Molecular Epidemiology. AIDS Res Hum Retroviruses (2015) 0.78
The influence of depressive symptoms on alcohol use among HIV-infected Russian drinkers. Drug Alcohol Depend (2013) 0.76
Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach. Harm Reduct J (2017) 0.75
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications. J Urban Health (2009) 3.00
High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav (2010) 2.18
Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. Int J STD AIDS (2003) 2.07
The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health (2009) 1.95
HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr (2006) 1.77
Commercial sex work, drug use, and sexually transmitted infections in St. Petersburg, Russia. Soc Sci Med (2004) 1.74
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. AIDS (2006) 1.48
Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. Eur J Public Health (2010) 1.37
Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples. Contemp Clin Trials (2012) 1.33
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev (2011) 1.32
Potential bridges of heterosexual HIV transmission from drug users to the general population in St. Petersburg, Russia: is it easy to be a young female? J Urban Health (2009) 1.32
Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia. BMC Public Health (2010) 1.28
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.15
Estimation of the number of injection drug users in St. Petersburg, Russia. Drug Alcohol Depend (2010) 1.15
Clients of street-based female sex workers and potential bridging of HIV/STI in Russia: results of a pilot study. AIDS Care (2012) 1.02
Five-year trends in epidemiology and prevention of mother-to-child HIV transmission, St. Petersburg, Russia: results from perinatal HIV surveillance. BMC Infect Dis (2011) 0.97
HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav (2011) 0.94
HIV diagnosis at CD4 count above 500 cells/mm3 and progression to below 350 cells/mm3 without antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 0.87
Sexual networks and sexually transmitted infections: innovations and findings. Curr Opin Infect Dis (2011) 0.86
[The clean syringe and HIV infection. A clean syringe can be obtained by any drug addict in a bus stationed in places of active drug trading]. Zh Mikrobiol Epidemiol Immunobiol (1999) 0.82
Rejecting the evidence: Russia's drug dependence treatment system. HIV AIDS Policy Law Rev (2008) 0.79
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet (2010) 3.29
Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin Infect Dis (2006) 3.06
Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications. J Urban Health (2009) 3.00
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction (2011) 2.95
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction (2004) 2.44
Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction (2008) 2.42
Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 2.33
Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis (2010) 2.32
Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis. Sci Transl Med (2013) 2.28
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet (2008) 2.27
If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction (2009) 2.25
Spatial analysis of human granulocytic ehrlichiosis near Lyme, Connecticut. Emerg Infect Dis (2002) 2.21
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav (2010) 2.18
Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. Int J STD AIDS (2003) 2.07
Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice. Ann Epidemiol (2011) 2.05
The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health (2009) 1.95
Police training to align law enforcement and HIV prevention: preliminary evidence from the field. Am J Public Health (2011) 1.94
HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr (2006) 1.77
Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev (2012) 1.68
The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs. Addiction (2010) 1.67
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology (2011) 1.67
Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis. Sci Transl Med (2012) 1.65
Bacterial analysis by MALDI-TOF mass spectrometry: an inter-laboratory comparison. J Am Soc Mass Spectrom (2005) 1.62
Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health (2008) 1.61
Illicit use of opioids: is OxyContin a "gateway drug"? Am J Addict (2007) 1.59
Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health (2007) 1.57
Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J R Soc Interface (2007) 1.54
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol (2011) 1.50
Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities. Drug Alcohol Depend (2005) 1.38
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis (2013) 1.38
Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect (2010) 1.38
Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. Eur J Public Health (2010) 1.37
No coexistence for free: neutral null models for multistrain pathogens. Epidemics (2008) 1.37
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia. Med J Aust (2012) 1.33
Mathematical modelling of hepatitis C treatment for injecting drug users. J Theor Biol (2011) 1.32
Potential bridges of heterosexual HIV transmission from drug users to the general population in St. Petersburg, Russia: is it easy to be a young female? J Urban Health (2009) 1.32
Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia. BMC Public Health (2010) 1.28
Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS (2013) 1.28
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction (2009) 1.27
Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission. J Infect Dis (2013) 1.26
Positive impact of a large-scale HIV prevention programme among female sex workers and clients in South India. AIDS (2013) 1.26
Intraocular pressure measurement precision with the Goldmann applanation, dynamic contour, and ocular response analyzer tonometers. Ophthalmology (2010) 1.25
A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India. BMC Public Health (2011) 1.25
Expanding harm reduction services through a wound and abscess clinic. Am J Public Health (2002) 1.24
Condoms and prevention of HIV. BMJ (2004) 1.23
Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis (2008) 1.23
Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend (2010) 1.23
High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS (2007) 1.22
The impact of out-migrants and out-migration on the HIV/AIDS epidemic: a case study from south-west India. AIDS (2008) 1.20
Estimation of the number of injection drug users in St. Petersburg, Russia. Drug Alcohol Depend (2010) 1.15
Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend (2010) 1.15
Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? Addiction (2007) 1.14
Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS Behav (2005) 1.14
Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics. Nature (2006) 1.13
A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J (2008) 1.12
The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy. Invest Ophthalmol Vis Sci (2010) 1.11
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Estimating the distribution of a renewal process from times at which events from an independent process are detected. Biometrics (2006) 1.06
How the dynamics and structure of sexual contact networks shape pathogen phylogenies. PLoS Comput Biol (2013) 1.05
Models to understand the population-level impact of mixed strain M. tuberculosis infections. J Theor Biol (2011) 1.04
Clients of street-based female sex workers and potential bridging of HIV/STI in Russia: results of a pilot study. AIDS Care (2012) 1.02
The expression of the developmentally regulated proto-oncogene Pax-3 is modulated by N-Myc. J Biol Chem (2002) 1.01
Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open (2013) 1.00
Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc Natl Acad Sci U S A (2008) 1.00
The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes. Mol Cell Biol (2007) 0.99
Remodelling core group theory: the role of sustaining populations in HIV transmission. Sex Transm Infect (2010) 0.99
Policy resistance to harm reduction for drug users and potential effect of change. BMJ (2010) 0.98
The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction (2004) 0.98
The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh. Addiction (2009) 0.97
Peridomestic Lyme disease prevention: results of a population-based case-control study. Am J Prev Med (2009) 0.96
Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS One (2008) 0.96
Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union? Addiction (2006) 0.96
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open (2013) 0.95
Drug network characteristics and HIV risk among injection drug users in Russia: the roles of trust, size, and stability. AIDS Behav (2011) 0.95
The relative role of perceived partner risks in promoting condom use in a three-city sample of high-risk, low-income women. AIDS Behav (2011) 0.95
The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries. AIDS Res Hum Retroviruses (2007) 0.94
HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav (2011) 0.94
Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups. Harm Reduct J (2013) 0.94
Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. Int J Drug Policy (2008) 0.94
Mathematical models of the epidemiology and control of drug-resistant TB. Expert Rev Respir Med (2009) 0.94
Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. BMC Health Serv Res (2014) 0.93
Law enforcement attitudes toward overdose prevention and response. Drug Alcohol Depend (2013) 0.93
Community mobilization and empowerment of female sex workers in Karnataka State, South India: associations with HIV and sexually transmitted infection risk. Am J Public Health (2014) 0.92
Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia. Harm Reduct J (2009) 0.92
Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. BMC Public Health (2013) 0.92
Inferring carbon sources from gene expression profiles using metabolic flux models. PLoS One (2012) 0.92